To help Asia-Pacific emerging biopharmaceutical companies achieve their growth aspirations, Quintiles today launched a new solution set tailored to meet the needs of emerging companies in the world s most diverse and dynamic healthcare market. Asia-Pacific is poised to become the world s next biopharma powerhouse, not least because of its
-Amarantus BioSciences Holdings, Inc., a biotechnology company focused on developing therapeutic and diagnostic products for neurological disorders and orphan indications, announced that it has implemented a 1- for-150 reverse stock split of its common stock. In addition, we believe the potential addition of the clinical-stage orphan candidate ESS,
DALLAS, May 24, 2015/ PRNewswire-iReach/ The report " Arrhythmias Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Arrhythmias, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action, route of administration and molecule type, along with l
Baxter International reported that the U.S. Food and Drug Administration has approved the company's supplemental drug application to establish its Sabinanigo, Spain, facility as an approved manufacturing site for 0.9 percent Sodium Chloride Injection, USP, for the U.S. market. In a release, the Company noted that the approval includes product prese
EU Falsified Medicines Directive When benchmarking for expertise and experience in operating a Medicine Verification Service, look for EU Member States who have a fully operational system in place, not a pilot. Pick an Aegate country: for example BELGIUM. Over 6,000 pharmaceutical manufacturers must serialise and add tamper proofing to roughly 1
By a News Reporter-Staff News Editor at Medical Letter on the CDC& FDA Bayer HealthCare announced that a study published online this week in The Journal of Minimally Invasive Gynecology reinforces findings from previous clinical studies that support the effectiveness and safety of the Essure inserts and procedure for hysteroscopic sterilizatio
Kolltan Pharmaceuticals recently reported that Joseph Schlessinger, Ph.D., Chairman of the Department of Pharmacology and the William H. Prusoff Professor at Yale University School of Medicine, as well as founding director of Yale's Cancer Biology Institute and co-founder of Kolltan, has been named one of the top 100 most influential people in drug
As a step towards sanitizing the chaotic drug distribution in the country, the Pharmaceutical Society of Nigeria has at last floated a limited liability company, UltraLogistics, that would operate a modern mega distribution network. At the official launch of the company profile and private placement memorandum recently held in Lagos, President of t
The right hand he used to play basketball in college and then combat fires near Sacramento and Modesto for nearly three decades has withered and rests, immobilized, in a splint. Part of a growing movement dubbed "right to try," the legislation would allow Californians with fatal diseases to petition pharmaceutical companies directly for experimenta
-ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it will present at the 2015 Marcum MicroCap Conference on May 28, 2015 in New York City at the Grand Hyatt New York.
-Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced today that Daniel J. O'Connor, President and Chief Executive Officer of Advaxis, will present at the 2015 Jefferies Global Healthcare Conference being held June 1-4, 2015 in New York, NY. Advaxis entered into a clinical trial collaboration with MedIm
-The ALS Therapy Development Institute expanded its Kendall Square team recently when it filled four new research positions with scientists and technicians, all of whom are highly qualified in their specific fields. Calo has undertaken successful internships as a researcher and laboratory technician in academia and the pharmaceutical industry,...
Atyr Pharma Inc. Files SEC Form CERTNAS, Certification By The National Association of Securities Dealers Automated Quotation Approving Securities For Listing. By a News Reporter-Staff News Editor at Investment Weekly News According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and Exchange...
-Galena Biopharma, Inc., a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today announced that data from the Company's Phase 2 clinical trial of GALE-401, or Anagrelide Controlled Release, will be presented at the upcoming.
The Mexican Supreme Court by the end of 2013, published a landmark decision that now is publically obtainable that certainly will impact the legal framework of the Pharmaceutical Industry in Mexico. The Regulatory Agency in charge of granting the marketing authorizations in Mexico granted a generic company an approval for the same product as...
Strides Arcolab announced that Strides Pharma Global Pte. Ltd, Singapore and Strides (Australia) Pharma Pty Ltd, Australia, both wholly owned subsidiaries of Strides Arcolab have signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacare Holdings Limited, a company listed on the Johannesburg Stock Exchange (Aspen), to a
By a News Reporter-Staff News Editor at Marketing Weekly News The fairness of the proposed acquisition of Synageva Biopharma Corp. by Alexion Pharmaceuticals, Inc. is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm, for possible breaches of fiduciary duty and other violations of law by the Board of Directo
-Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, today announced that Steven Gannon has been appointed to its Board of Directors, where he will also serve on the Company's Audit Committee. His past executive experience includes serving as Chief Financial Officer, Senior Vice President of Finance, and Treasurer at Aptalis Pha
Research and Markets has announced the addition of the "Latest Regulations on Pharmaceutical International Multi-Center Clinical Trials in China" report to their offering. This is first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical trials of drugs in China, which has begun
-AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors, today announces the publication of a wide-ranging independent review article entitled' Masitinib for the treatment of mild to moderate Alzheimer's disease' in the peer-reviewed journal Expert Review of...
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that interim chief executive officer Howie Rosen will be presenting at Jefferies 2015 Healthcare Conference and chief financial officer Tim...
Before becoming CEO in 2013, Mr. Asako was the Chief Financial Officer of DeNA West and before that, served as CFO of MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange. He also has experience in the management of U.S. biopharmaceutical companies and publicly listed com
ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it will present at the 2015 Marcum MicroCap Conference on May 28, 2015 in New York City at the Grand Hyatt New York.
Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, announced today that Daniel J. O'Connor, President and Chief Executive Officer of Advaxis, will present at the 2015 Jefferies Global Healthcare Conference being held June 1-4, 2015 in New York, NY. Advaxis entered into a clinical trial collaboration with MedI
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry: Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled, "Guidance for